vs
Side-by-side financial comparison of Porch Group, Inc. (PRCH) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $103.7M, roughly 1.2× Twist Bioscience Corp). Porch Group, Inc. runs the higher net margin — -3.9% vs -29.4%, a 25.5% gap on every dollar of revenue. On growth, Porch Group, Inc. posted the faster year-over-year revenue change (100.0% vs 16.9%).
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
PRCH vs TWST — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $121.1M | $103.7M |
| Net Profit | $-4.7M | $-30.5M |
| Gross Margin | 52.7% | 52.0% |
| Operating Margin | 34.7% | -31.7% |
| Net Margin | -3.9% | -29.4% |
| Revenue YoY | 100.0% | 16.9% |
| Net Profit YoY | 2.0% | 3.4% |
| EPS (diluted) | $-0.04 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $121.1M | — | ||
| Q4 25 | $112.3M | $103.7M | ||
| Q3 25 | $115.1M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $84.5M | — | ||
| Q4 24 | $75.3M | — | ||
| Q3 24 | $77.7M | — | ||
| Q2 24 | $75.9M | — |
| Q1 26 | $-4.7M | — | ||
| Q4 25 | $-3.5M | $-30.5M | ||
| Q3 25 | $-10.9M | — | ||
| Q2 25 | $2.6M | — | ||
| Q1 25 | $8.4M | — | ||
| Q4 24 | $30.5M | — | ||
| Q3 24 | $14.4M | — | ||
| Q2 24 | $-64.3M | — |
| Q1 26 | 52.7% | — | ||
| Q4 25 | 99.5% | 52.0% | ||
| Q3 25 | 75.6% | — | ||
| Q2 25 | 70.9% | — | ||
| Q1 25 | 77.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 79.4% | — | ||
| Q2 24 | 22.1% | — |
| Q1 26 | 34.7% | — | ||
| Q4 25 | 14.7% | -31.7% | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | -1.5% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | -3.2% | — | ||
| Q2 24 | -69.2% | — |
| Q1 26 | -3.9% | — | ||
| Q4 25 | -3.1% | -29.4% | ||
| Q3 25 | -9.4% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 40.5% | — | ||
| Q3 24 | 18.5% | — | ||
| Q2 24 | -84.8% | — |
| Q1 26 | $-0.04 | — | ||
| Q4 25 | $0.00 | $-0.50 | ||
| Q3 25 | $-0.10 | — | ||
| Q2 25 | $0.00 | — | ||
| Q1 25 | $0.07 | — | ||
| Q4 24 | $0.34 | — | ||
| Q3 24 | $0.12 | — | ||
| Q2 24 | $-0.65 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $68.4M | $197.9M |
| Total DebtLower is stronger | $391.3M | — |
| Stockholders' EquityBook value | $26.3M | $456.1M |
| Total Assets | $806.6M | $638.1M |
| Debt / EquityLower = less leverage | 14.87× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $68.4M | — | ||
| Q4 25 | $57.3M | $197.9M | ||
| Q3 25 | $85.0M | — | ||
| Q2 25 | $79.8M | — | ||
| Q1 25 | $70.4M | — | ||
| Q4 24 | $191.7M | — | ||
| Q3 24 | $238.6M | — | ||
| Q2 24 | $308.4M | — |
| Q1 26 | $391.3M | — | ||
| Q4 25 | $392.8M | — | ||
| Q3 25 | $387.1M | — | ||
| Q2 25 | $394.1M | — | ||
| Q1 25 | $409.2M | — | ||
| Q4 24 | $403.9M | — | ||
| Q3 24 | $399.0M | — | ||
| Q2 24 | $436.8M | — |
| Q1 26 | $26.3M | — | ||
| Q4 25 | $-24.6M | $456.1M | ||
| Q3 25 | $-27.9M | — | ||
| Q2 25 | $-29.3M | — | ||
| Q1 25 | $-52.4M | — | ||
| Q4 24 | $-43.2M | — | ||
| Q3 24 | $-77.0M | — | ||
| Q2 24 | $-101.9M | — |
| Q1 26 | $806.6M | — | ||
| Q4 25 | $797.4M | $638.1M | ||
| Q3 25 | $787.7M | — | ||
| Q2 25 | $770.7M | — | ||
| Q1 25 | $802.3M | — | ||
| Q4 24 | $814.0M | — | ||
| Q3 24 | $867.3M | — | ||
| Q2 24 | $876.1M | — |
| Q1 26 | 14.87× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $-24.8M |
| Free Cash FlowOCF − Capex | — | $-34.8M |
| FCF MarginFCF / Revenue | — | -33.5% |
| Capex IntensityCapex / Revenue | — | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.2M | $-24.8M | ||
| Q3 25 | $40.8M | — | ||
| Q2 25 | $35.6M | — | ||
| Q1 25 | $-11.2M | — | ||
| Q4 24 | $-26.6M | — | ||
| Q3 24 | $12.4M | — | ||
| Q2 24 | $-26.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.1M | $-34.8M | ||
| Q3 25 | $40.7M | — | ||
| Q2 25 | $35.4M | — | ||
| Q1 25 | $-11.2M | — | ||
| Q4 24 | $-26.8M | — | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $-26.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.0% | -33.5% | ||
| Q3 25 | 35.4% | — | ||
| Q2 25 | 33.0% | — | ||
| Q1 25 | -13.3% | — | ||
| Q4 24 | -35.6% | — | ||
| Q3 24 | 15.7% | — | ||
| Q2 24 | -34.3% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | 9.6% | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 13.79× | — | ||
| Q1 25 | -1.33× | — | ||
| Q4 24 | -0.87× | — | ||
| Q3 24 | 0.86× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCH
Segment breakdown not available.
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
